1. Home
  2. ADXN vs JTAI Comparison

ADXN vs JTAI Comparison

Compare ADXN & JTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADXN
  • JTAI
  • Stock Information
  • Founded
  • ADXN 2002
  • JTAI 2018
  • Country
  • ADXN Switzerland
  • JTAI United States
  • Employees
  • ADXN N/A
  • JTAI N/A
  • Industry
  • ADXN Biotechnology: Pharmaceutical Preparations
  • JTAI Blank Checks
  • Sector
  • ADXN Health Care
  • JTAI Finance
  • Exchange
  • ADXN Nasdaq
  • JTAI Nasdaq
  • Market Cap
  • ADXN 10.1M
  • JTAI 9.9M
  • IPO Year
  • ADXN N/A
  • JTAI N/A
  • Fundamental
  • Price
  • ADXN $8.83
  • JTAI $3.70
  • Analyst Decision
  • ADXN Strong Buy
  • JTAI
  • Analyst Count
  • ADXN 1
  • JTAI 0
  • Target Price
  • ADXN $30.00
  • JTAI N/A
  • AVG Volume (30 Days)
  • ADXN 14.6K
  • JTAI 211.4K
  • Earning Date
  • ADXN 08-11-2025
  • JTAI 08-13-2025
  • Dividend Yield
  • ADXN N/A
  • JTAI N/A
  • EPS Growth
  • ADXN N/A
  • JTAI N/A
  • EPS
  • ADXN 0.10
  • JTAI N/A
  • Revenue
  • ADXN $278,508.00
  • JTAI $13,648,668.00
  • Revenue This Year
  • ADXN $86.57
  • JTAI $13.37
  • Revenue Next Year
  • ADXN N/A
  • JTAI $201.13
  • P/E Ratio
  • ADXN $0.78
  • JTAI N/A
  • Revenue Growth
  • ADXN N/A
  • JTAI N/A
  • 52 Week Low
  • ADXN $6.51
  • JTAI $2.30
  • 52 Week High
  • ADXN $13.27
  • JTAI $97.40
  • Technical
  • Relative Strength Index (RSI)
  • ADXN 49.41
  • JTAI 49.53
  • Support Level
  • ADXN $8.78
  • JTAI $3.33
  • Resistance Level
  • ADXN $9.89
  • JTAI $3.75
  • Average True Range (ATR)
  • ADXN 0.67
  • JTAI 0.21
  • MACD
  • ADXN -0.03
  • JTAI 0.03
  • Stochastic Oscillator
  • ADXN 43.01
  • JTAI 59.68

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.

About JTAI Jet.AI Inc.

Jet AI Inc is principally involved in the sale of jet cards, which enable holders to use certain aircraft owned, leased by, arranged, and/or managed by Jet Token and others at agreed-upon rates, as well as the sale of fractional interests in aircraft; and the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third party carriers as well as via Jet Token's leased and managed aircraft.

Share on Social Networks: